U.S. stock index futures opened mixed on Friday as investors assessed a week of earnings reports, with Netflix’s strong results providing a notable boost to market sentiment. Dow Jones Industrial Average futures slipped due to weakness in Procter & Gamble, while the S&P 500 and Nasdaq 100 futures were buoyed by Netflix’s impressive third-quarter performance. Despite mixed signals, optimism surrounding corporate earnings continues to support the broader market.
Netflix shares surged 7% after the streaming company surpassed Wall Street expectations in both earnings and revenue for the third quarter. Netflix reported earnings per share of $5.40, exceeding the expected $5.12, and revenue of $9.83 billion, above the forecasted $9.77 billion. The company also saw a 35% quarter-over-quarter increase in its ad-tier memberships, reflecting growing demand for its ad-supported service. This positive performance lifted sentiment in the Nasdaq 100, helping offset some of the broader market’s uncertainties.
Analysts remain bullish on Netflix. JPMorgan’s Doug Anmuth reaffirmed his overweight rating on the stock, forecasting balanced growth ahead as the ad-supported model scales. Morgan Stanley’s Benjamin Swinburne also maintained an overweight rating, calling Netflix’s results a success and projecting further upside potential.
Procter & Gamble (P&G) shares fell 0.8% after the company reported weaker-than-expected revenue for the quarter. P&G posted $21.74 billion in revenue, missing analysts’ expectations of $21.91 billion, which the company attributed to reduced demand in China. However, P&G’s adjusted earnings per share of $1.93 slightly exceeded estimates of $1.90. Despite the earnings beat, the revenue shortfall weighed on investor sentiment, dragging Dow futures lower.
CVS Health shares tumbled 11% in premarket trading following the announcement that longtime executive David Joyner would replace Karen Lynch as CEO. The leadership transition, combined with lowered third-quarter earnings guidance, added to investor concerns. CVS now expects adjusted earnings of $1.05 to $1.10 per share, significantly below the $1.69 forecasted by analysts. The company’s outlook sent shockwaves through the market, contributing to the stock’s sharp decline.
Apple shares climbed 2% in premarket trading after reports indicated stronger-than-expected sales of the new iPhone 16 in China. According to data from Counterpoint Research, sales in the first three weeks were up 20% compared to the iPhone 15, suggesting a successful product launch.
Nvidia also advanced, with shares up 1% after Bank of America reiterated a buy rating and projected nearly 40% upside for the stock. Nvidia’s CEO recently highlighted strong demand for the company’s Blackwell chip, further boosting confidence in its long-term growth prospects.
Heading into next week, U.S. markets appear poised for further gains, supported by robust corporate earnings. The Nasdaq, buoyed by Netflix and tech sector strength, could lead the way higher. However, mixed signals from major companies like P&G and CVS may introduce pockets of volatility. Traders should keep a close eye on upcoming earnings reports and economic data, which could shape the market’s short-term direction. Overall, the tone remains cautiously optimistic, with a slight bullish bias for the broader indices.
James is a Florida-based technical analyst, market researcher, educator and trader with 35+ years of experience. He is an expert in the area of patterns, price and time analysis as it applies to futures, Forex, and stocks.